The PennZone

  • Home
  • Business
  • Non-profit
  • Health
  • Technology
  • Real Estate
  • Entertainment
  • Music
  • Travel

Utah attempts to legalize placenta cell therapy
The PennZone/10266985

Trending...
  • Precision Adult Care Expands 24/7 Adult In-Home Care Services to Meet Growing Demand in the Coachella Valley
  • From Factory Floor to Community Heart: The Rebel Spirit of Wisconsin's Wet Wipe Innovators
  • Michael Judkins Releases New Poetry Book, Deeper Than You Think
Parent's Guide to Cord Blood Foundation
Exclusive: How a small group of patient advocates and biotech companies tricked the Utah legislature into passing a law which sets a precedent. Utah is now the first state to legalize therapy with stem cells from placenta tissue and cord blood.

BROOKEVILLE, Md. - PennZone -- Exclusive: How a small group of patient advocates and biotech companies tricked the Utah legislature into passing a law which sets a precedent. Utah is now the first state to legalize therapy with stem cells from placenta tissue and cord blood.

Parent's Guide to Cord Blood Foundation is a small non-profit in the biotech space. We are the first to break the story that the Utah state legislature did not realize what they were voting for when they passed Utah S.B. 199.

More on The PennZone
  • P‑Wave Classics Launches Definitive New Edition of Hannah Webster Foster's The Coquette
  • Strategic Expansion with 3 New Alliances — Jefferson Beach Yacht Sales, CFR YS & flyExclusive Incentive Partnership: Off The Hook YS: (N Y S E: OTH)
  • Super League (N A S D A Q: SLE) Advances AI-Driven Playable Media with AdArcade, Solsten, and Meta-Stadiums Partnerships, Plus Roblox Theatre Launch
  • purelyIV Expands Concierge Wellness Platform with New IV Therapies, Memberships, and Digital Experience
  • CCHR: Europe Rejects Forced Psychiatry—Landmark Vote Declares Coercive Practices Incompatible with Human Rights

The FDA still considers unapproved stem cell therapies to be illegal, and when it comes to drug regulations, federal law takes supremacy. This is not the same as states ignoring federal law and legalizing recreational drugs. In the case of stem cell therapy, patients that receive unregulated products with insufficient oversight could suffer serious adverse events. The new law Utah S.B. 199 is going to trigger a showdown between the federal government and Utah. Doctors who administer therapy to patients under the new Utah law could be sued by the Dept. of Justice. At a bare minimum, we are calling for the state of Utah to establish oversight of this arena before patients are hurt.

Contact
Frances Verter, PhD
***@parentsguidecordblood.org


Source: Parent's Guide to Cord Blood Foundation

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Daniel Guest of Imagen Golf Named to GRAA Top 100 Emerging Golf Professionals
  • InspireTech Global and SKADI Cyber Defense Announce Strategic Partnership to Deliver Autonomous Cybersecurity to Canadian Education and Public Sector
  • Kaltra Expands Microchannel Innovation to Deliver Lower Refrigerant Charge
  • Georgia's Lanier Islands Resort Tees Up for a New Era of Golf in Spring 2026
  • We Have Lots Of Loads LLC Expands Nationwide
  • Eagle Americas Expands Into the Western U.S. With High West Machine Tool
  • Desert Mountain Club Earns Prestigious Blue Zones Approved™ Triple Designation, a New Standard for Well-Being in a Luxury Lifestyle Community
  • Outsports announces record-breaking number of LGBTQ+ athletes at 2026 Milan Winter Olympics
  • Sheffield Clinic Highlights Safe, Inclusive Laser Hair Removal While Improving Access
  • Appliance EMT Partners with Kids Motel Ministry in Metro Atlanta
  • CNCPW Divulga Dados de Liquidez do 1º Trimestre: Confirma 100% de Reservas e Atualiza Protocolos de "Saque CNCPW" Contra Fluxos Ilícitos
  • Tech Workers Are Escaping "Forever Layoffs" By Becoming Their Own Boss
  • Michael Judkins Releases New Poetry Book, Deeper Than You Think
  • Heritage at South Brunswick Celebrates First Home Closing and Strong Sales Momentum
  • WinkBeds High-Performance Hybrid Mattresses Debut at Sleep Basil Denver With In-Store Comfort Testing
  • Tampa Nonprofit Expands Recovery Services for Men in Crisis With New Farm Program in Plant City
  • IYKYK! Coffee Lab Thriving in Huntington Beach, Blending Elevated Coffee, Matcha, Music, and Community
  • Accountants Near Me Cheyenne Opens U.S. Directory for Accountants, Bookkeepers and Tax Services
  • Sacred Surrogacy, CFC, and Egghelpers Launch Women's Retreats
  • The Eichelberger Performing Arts Center Donates Theatrical Lights to Delone Catholic High School

Popular on PennZone

  • Mark Schork Selected As 'Board Observer' By Philadelphia Bar Foundation
  • Pawprint Oxygen Turns Pet Safety Viral With "Pets Live Here" Window Decals — Helping First Responders Save Lives
  • Custom Home Builder Connecticut Valley Homes Wins 2025 Home of the Year from the Modular Home Builders Association
  • Bargeld Financial Launches Professional, Affordable Tax Preparation Services for the 2026 Tax Season
  • RNHA Affirms Support for President Trump as Nation Marks Historic Victory for Freedom
  • Yunishigawa Onsen's Annual "Kamakura Festival" will be held January 30 – March 1, 2026
  • CCHR: Harvard Review Exposes Institutional Corruption in Global Mental Health
  • High-End Exterior House Painting in Boulder, Colorado
  • Food Journal Magazine Releases Its 'Best Food In Los Angeles Dining' Editorial Section
  • Premium Bail Bonds Proudly Sponsors BOFAB BBQ Team at the 2026 Lakeland Pigfest

Similar on PennZone

  • Stipenda Appoints David Epstein as Chief Operating Officer
  • Metavalis Launches Massive Community Coat Drive in Branson to Support Local Residents
  • Crossroads4Hope Welcomes New Trustees to Board of Directors as Organization Enters 25th Year of Caring
  • SNS Research Launches SNS Market Intelligence Platform for visual market intelligence for pharma
  • High-Impact Mental Health Platform Approaching a Defining Regulatory Moment: Eclipsing 70,000 Patients on Real World Use of Ketamine: N ASDAQ: NRXP
  • AI-Driven Drug Development with Publication of New Bioinformatics Whitepaper for BullFrog AI: $BFRG Strengthens Its Position in AI Drug Development
  • VSee Health (N A S D A Q: VSEE) Secures $6.0M At-Market Investment, Accelerates Expansion as Revenues Surge
  • High-Conviction CNS Disruptor Aiming to Transform Suicidal Depression, Ketamine Therapeutics, and TMS - Reaching Millions by 2030
  • OKAVA Pharmaceuticals Announces First Cat Dosed in MEOW-1 Study of OKV-119, the World's First Clinical-Stage GLP-1 Weight-Loss Therapy for Pets
  • FDA Accepts ANDA for KETAFREE™ as Analyst Sets $34 Price Target for NRx Pharmaceuticals: (N A S D A Q : NRXP) NRx is Poised for a massive Breakthrough
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us